Severe Depressive Episode with Psychotic Symptoms and Type 2 Diabetes: A 2010-2017 Longitudinal Study.


Journal

Medical science monitor : international medical journal of experimental and clinical research
ISSN: 1643-3750
Titre abrégé: Med Sci Monit
Pays: United States
ID NLM: 9609063

Informations de publication

Date de publication:
08 Mar 2019
Historique:
entrez: 9 3 2019
pubmed: 9 3 2019
medline: 23 5 2019
Statut: epublish

Résumé

BACKGROUND There have been few studies published on the prevalence of severe depressive episode in people with type 2 diabetes (T2DM) or its role in adherence to dietary recommendations. We examined the Polish National Health Fund (NFZ) database estimates of all medical visits from 2010 to 2017 to determine the trend and the epidemiology of severe depressive episode in T2DM. MATERIAL AND METHODS The NFZ database was used. We defined the T2DM group diagnosed with both T2DM and severe depressive episode according to the ICD-10 codes. The annual prevalence of severe depressive episode was estimated according to the T2DM diagnosis status, and the age groups were stratified into 8 groups. RESULTS Relative risk for depression (regardless of severity of symptoms) in T2DM is 1.347 [95%CI: 1.342-1.353]. The frequency trend of severe depressive episode with or without psychotic symptoms remains relatively stable. In the case of mild and moderate depressive episode, a downward trend was noted, but they are still the most frequent mood disorders diagnosed. Patients with T2DM aged 20 to 40, for whom the peak of coexistence of these illnesses was noted, are the group particularly vulnerable to depression. Depression also remains on a relatively high but stable level for patients over 60 years of age. CONCLUSIONS The coexistence of depressive episodes in T2DM is a key challenge for medicine and public health. Measures aimed at early identification of patients with T2DM prone to depression need to be taken. Creating multidisciplinary care teams in diabetes management is also necessary.

Identifiants

pubmed: 30846676
pii: 913356
doi: 10.12659/MSM.913356
pmc: PMC6419531
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1760-1768

Références

Diabetes Care. 2001 Jun;24(6):1069-78
pubmed: 11375373
J Clin Epidemiol. 2004 Sep;57(9):978-84
pubmed: 15504641
J Gen Intern Med. 2006 Oct;21(10):1036-41
pubmed: 16836628
Diabetes Care. 2008 Jan;31(1):105-7
pubmed: 17934145
Diabetes Res Clin Pract. 2010 Jan;87(1):4-14
pubmed: 19896746
Diabetes Care. 2010 May;33(5):1061-4
pubmed: 20185747
Psychiatr Pol. 2010 May-Jun;44(3):319-28
pubmed: 20672512
Diabetologia. 2010 Dec;53(12):2480-6
pubmed: 20711716
Arch Intern Med. 2010 Nov 22;170(21):1884-91
pubmed: 21098346
Psychosomatics. 2011 Jan-Feb;52(1):1-18
pubmed: 21300190
Patient Educ Couns. 2013 Mar;90(3):392-8
pubmed: 21855266
Indian J Endocrinol Metab. 2011 Oct;15(4):274-83
pubmed: 22028998
Br J Gen Pract. 2012 Jan;62(594):e55-63
pubmed: 22520683
J Affect Disord. 2012 Oct;142 Suppl:S8-21
pubmed: 23062861
Cardiovasc Psychiatry Neurol. 2013;2013:695925
pubmed: 23653854
Diabetes Metab Syndr Obes. 2013 Nov 06;6:421-6
pubmed: 24232691
Curr Diab Rep. 2014 Jun;14(6):491
pubmed: 24743941
Endocrine. 2015 Feb;48(1):14-24
pubmed: 24927794
Postgrad Med J. 2014 Oct;90(1068):552-6
pubmed: 25092455
Drugs. 2015 Apr;75(6):577-87
pubmed: 25851098
Psychosom Med. 2015 May;77(4):467-77
pubmed: 25867970
PLoS One. 2015 May 26;10(5):e0127161
pubmed: 26010615
Depress Anxiety. 2015 Oct;32(10):763-73
pubmed: 26114259
Diabetes Care. 2016 Sep;39(9):1635-42
pubmed: 27486237
Psychosomatics. 2017 Jan - Feb;58(1):28-37
pubmed: 27692654
JAMA. 2017 May 23;317(20):2114-2122
pubmed: 28535241
Noro Psikiyatr Ars. 2017 Mar;54(1):49-56
pubmed: 28566959
Br J Clin Psychol. 2018 Mar;57(1):42-58
pubmed: 28691375
Patient Prefer Adherence. 2017 Jul 14;11:1221-1233
pubmed: 28761335
Nat Rev Endocrinol. 2018 Feb;14(2):88-98
pubmed: 29219149
BMC Res Notes. 2018 Jan 16;11(1):38
pubmed: 29338774
J Pak Med Assoc. 2018 Jan;68(1):109-111
pubmed: 29371729

Auteurs

Mariusz Jaworski (M)

Division of Teaching and Outcomes of Education, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

Mariusz Panczyk (M)

Division of Teaching and Outcomes of Education, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

Andrzej Śliwczyński (A)

Department of Analysis and Strategy, The National Health Fund, Warsaw, Poland.

Melania Brzozowska (M)

Department of Analysis and Strategy, The National Health Fund, Warsaw, Poland.

Katarzyna Janaszek (K)

Department of Analysis and Strategy, The National Health Fund, Warsaw, Poland.

Piotr Małkowski (P)

Department of Surgical and Transplant Nursing and Extracorporeal Treatment, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

Joanna Gotlib (J)

Division of Teaching and Outcomes of Education, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH